Diabetes 54:1884-1891, 2005
© 2005 by the American Diabetes Association, Inc.
Association Testing of the Protein Tyrosine Phosphatase 1B Gene (PTPN1) With Type 2 Diabetes in 7,883 People
Jose C. Florez1,2,3,4,
Christina M. Agapakis1,3,
Noël P. Burtt3,
Maria Sun1,3,
Peter Almgren5,
Lennart Råstam6,
Tiinamaija Tuomi7,
Daniel Gaudet8,
Thomas J. Hudson9,
Mark J. Daly3,
Kristin G. Ardlie10,
Joel N. Hirschhorn3,11,12,
Leif Groop5, and
David Altshuler1,2,3,4,11
1 Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts
2 Department of Medicine (Diabetes Unit), Massachusetts General Hospital, Boston, Massachusetts
3 Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts
4 Department of Medicine, Harvard Medical School, Boston, Massachusetts
5 Department of Clinical Sciences—Diabetes and Endocrinology, University Hospital Malmö, Lund University, Malmö, Sweden
6 Department of Clinical Sciences, University Hospital Malmö, Lund University, Malmö, Sweden
7 Department of Medicine, Helsinki University Central Hospital, Folkhalsan Genetic Institute, Folkhalsan Research Center, and Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland
8 University of Montreal Community Genomic Center, Chicoutimi Hospital, Quebec, Canada
9 McGill University and Genome Quebec Innovation Centre, Montreal, Canada
10 Genomics Collaborative Division, SeraCare LifeSciences, Cambridge, Massachusetts
11 Department of Genetics, Harvard Medical School, Boston, Massachusetts
12 Divisions of Genetics and Endocrinology, Childrens Hospital, Boston, Massachusetts
Protein tyrosine phosphatase (PTP)-1B, encoded by the PTPN1 gene, inactivates the insulin signal transduction cascade by dephosphorylating phosphotyrosine residues in insulin signaling molecules. Due to its chromosomal location under a chromosome 20 linkage peak and the metabolic effects of its absence in knockout mice, it is a candidate gene for type 2 diabetes. Recent studies have associated common sequence variants in PTPN1 with type 2 diabetes and diabetes-related phenotypes. We sought to replicate the association of common single nucleotide polymorphisms (SNPs) and haplotypes in PTPN1 with type 2 diabetes, fasting plasma glucose, and insulin sensitivity in a large collection of subjects. We assessed linkage disequilibrium, selected tag SNPs, and typed these markers in 3,347 cases of type 2 diabetes and 3,347 control subjects as well as 1,189 siblings discordant for type 2 diabetes. Despite power estimated at >95% to replicate the previously reported associations, no statistically significant evidence of association was observed between PTPN1 SNPs or common haplotypes with type 2 diabetes or with diabetic phenotypes.
Address correspondence and reprint requests to Leif Groop, Department of Endocrinology, University Hospital MAS, Lund University, Malmö, Sweden. E-mail: leif.groop{at}med.lu.se. Or David Altshuler, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114. E-mail: altshuler{at}molbio.mgh.harvard.edu
Abbreviations:
CEPH, Centre dEtude du Polymorphisme Humain; GCI, Genomics Collaborative, Inc; ISI, insulin sensitivity index; LD, linkage disequilibrium; OGTT, oral glucose tolerance test; PTP, protein tyrosine phosphatase; SNP, single nucleotide polymorphism; UTR, untranslated region

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Meshkani, M. Taghikhani, H. Al-Kateb, B. Larijani, S. Khatami, G. K. Sidiropoulos, R. A. Hegele, and K. Adeli
Polymorphisms within the Protein Tyrosine Phosphatase 1B (PTPN1) Gene Promoter: Functional Characterization and Association with Type 2 Diabetes and Related Metabolic Traits
Clin. Chem.,
September 1, 2007;
53(9):
1585 - 1592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Watanabe, M. H. Black, A. H. Xiang, H. Allayee, J. M. Lawrence, and T. A. Buchanan
Genetics of Gestational Diabetes Mellitus and Type 2 Diabetes
Diabetes Care,
July 1, 2007;
30(Supplement_2):
S134 - S140.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. N. Lyon, J. C. Florez, T. Bersaglieri, R. Saxena, W. Winckler, P. Almgren, U. Lindblad, T. Tuomi, D. Gaudet, X. Zhu, et al.
Common Variants in the ENPP1 Gene Are Not Reproducibly Associated With Diabetes or Obesity
Diabetes,
November 1, 2006;
55(11):
3180 - 3184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Saxena, L. Gianniny, N. P. Burtt, V. Lyssenko, C. Giuducci, M. Sjogren, J. C. Florez, P. Almgren, B. Isomaa, M. Orho-Melander, et al.
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals.
Diabetes,
October 1, 2006;
55(10):
2890 - 2895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Das, W. S. Chu, T. C. Hale, X. Wang, R. L. Craig, H. Wang, A. R. Shuldiner, P. Froguel, P. Deloukas, M. I. McCarthy, et al.
Polymorphisms in the Glucokinase-Associated, Dual-Specificity Phosphatase 12 (DUSP12) Gene Under Chromosome 1q21 Linkage Peak Are Associated With Type 2 Diabetes
Diabetes,
September 1, 2006;
55(9):
2631 - 2639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Sun, J. Y. Lee, P. I.W. de Bakker, N. P. Burtt, P. Almgren, L. Rastam, T. Tuomi, D. Gaudet, M. J. Daly, J. N. Hirschhorn, et al.
Haplotype Structures and Large-Scale Association Testing of the 5' AMP-Activated Protein Kinase Genes PRKAA2, PRKAB1, and PRKAB2 With Type 2 Diabetes
Diabetes,
March 1, 2006;
55(3):
849 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|